New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Double testing better at identifying bowel cancer

Double testing better at identifying bowel cancer

byUniversity of EdinburghReceiver operating characteristic (ROC) curve analysis for the detection of colorectal cancer between cohorts. Area under the curve 0.85 (95% c.i. 0.80 to 0.90) for the
Oncology January 04,2024
Double testing better at identifying bowel cancer

Double testing better at identifying bowel cancer

byUniversity of EdinburghReceiver operating characteristic (ROC) curve analysis for the detection of colorectal cancer between cohorts. Area under the curve 0.85 (95% c.i. 0.80 to 0.90) for the
Oncology January 04,2024
How bispecific antibodies could bring new hope to patients with lung cancer

How bispecific antibodies could bring new hope to patients with lung cancer

by Cactus CommunicationsMOAs of bsAbs in the treatment of lung cancer. (A) One arm of a bsAb binds to TAA/TSA, and the other to a T-cell surface receptor, and this bridging mechanism redirects cytotox
Breakthroughs January 04,2024
How bispecific antibodies could bring new hope to patients with lung cancer

How bispecific antibodies could bring new hope to patients with lung cancer

by Cactus CommunicationsMOAs of bsAbs in the treatment of lung cancer. (A) One arm of a bsAb binds to TAA/TSA, and the other to a T-cell surface receptor, and this bridging mechanism redirects cytotox
Breakthroughs January 04,2024
Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

byAmerican Roentgen Ray SocietyContrast-enhanced multiphase DECT of chest performed for surgical planning. Axial image from iodine concentration map, reconstructed from equilibrium-phase acquisi
Medical imageology January 04,2024
Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

Dual-energy CT iodine concentration differentiates lung cancer from pulmonary metastases

byAmerican Roentgen Ray SocietyContrast-enhanced multiphase DECT of chest performed for surgical planning. Axial image from iodine concentration map, reconstructed from equilibrium-phase acquisi
Medical imageology January 04,2024
Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval
Oncology January 04,2024
Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval
Oncology January 04,2024
Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for
Oncology January 04,2024
Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for
Oncology January 04,2024
Two-pronged immunotherapy eliminates metastatic breast cancer in mice

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer
Oncology January 04,2024
Two-pronged immunotherapy eliminates metastatic breast cancer in mice

Two-pronged immunotherapy eliminates metastatic breast cancer in mice

by Julia Evangelou Strait,Washington University School of MedicineResearchers at Washington University School of Medicine in St. Louis have identified a way to sensitize metastatic breast cancer
Oncology January 04,2024
Twin study confirms childhood leukemia starts in the womb and could help guide screening when only one twin is affected

Twin study confirms childhood leukemia starts in the womb and could help guide screening when only one twin is affected

byInstitute of Cancer ResearchPre-leukaemic cells in blood of the healthy co-twin of a patient with t(9;22) ALL (pair 3A/B). A FISH for BCR::ABL1 translocation in PB mononuclear cells from twin
Pediatrics January 04,2024
Twin study confirms childhood leukemia starts in the womb and could help guide screening when only one twin is affected

Twin study confirms childhood leukemia starts in the womb and could help guide screening when only one twin is affected

byInstitute of Cancer ResearchPre-leukaemic cells in blood of the healthy co-twin of a patient with t(9;22) ALL (pair 3A/B). A FISH for BCR::ABL1 translocation in PB mononuclear cells from twin
Pediatrics January 04,2024
Dual-targeting CAR NK cells can prevent cell dysfunction and tumor escape

Dual-targeting CAR NK cells can prevent cell dysfunction and tumor escape

byUniversity of Texas M. D. Anderson Cancer CenterKaty Rezvani, M.D., Ph.D., working in her laboratory. Credit: MD Anderson Cancer CenterResearchers at The University of Texas MD Anderson Cancer
Breakthroughs January 04,2024
Dual-targeting CAR NK cells can prevent cell dysfunction and tumor escape

Dual-targeting CAR NK cells can prevent cell dysfunction and tumor escape

byUniversity of Texas M. D. Anderson Cancer CenterKaty Rezvani, M.D., Ph.D., working in her laboratory. Credit: MD Anderson Cancer CenterResearchers at The University of Texas MD Anderson Cancer
Breakthroughs January 04,2024
Aging and cancer hallmarks as therapeutic targets

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and
Oncology January 04,2024
Aging and cancer hallmarks as therapeutic targets

Aging and cancer hallmarks as therapeutic targets

by Compuscript LtdCrosstalk between aging and cancer hallmarks. (a) Aging hallmarks are categorized into five groups based on correlation with cancer hallmarks. (b) Hallmarks shared between aging and
Oncology January 04,2024
Digital breast tomosynthesis improves cancer screening in community settings

Digital breast tomosynthesis improves cancer screening in community settings

byRadiological Society of North AmericaCredit: Unsplash/CC0 Public DomainResearchers have found that digital breast tomosynthesis (DBT) has improved breast cancer screening performance in commun
Medical imageology January 04,2024
Digital breast tomosynthesis improves cancer screening in community settings

Digital breast tomosynthesis improves cancer screening in community settings

byRadiological Society of North AmericaCredit: Unsplash/CC0 Public DomainResearchers have found that digital breast tomosynthesis (DBT) has improved breast cancer screening performance in commun
Medical imageology January 04,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com